ENDLOS-TURBO PUT - AMGEN | Delayed Deutsche Boerse AG 08:34:33 04/07/2024 BST | ||
| 6.03 EUR | -3.98% |
|
| Current month | +2.95% | ||
| 1 month | -0.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 04/07/24 | 6.03 | -3.98% |
| 03/07/24 | 6.28 | +2.45% |
| 02/07/24 | 6.13 | -0.49% |
| 01/07/24 | 6.16 | +0.98% |
| 28/06/24 | 6.1 | +1.67% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 08:34 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2U7T |
| ISIN | DE000DJ2U7T8 |
| Date issued | 02/10/2023 |
| Strike | 376.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.23 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.27 € |
|---|---|
| Lowest since issue | 4.65 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Certificates
- Certificat
